Viewing nowIlseong Glimepiride Tablet 2mg
Glimepiride 2mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

MFDS item code 200401535 · Notified 2004.02.06 · Insurance code 655401330
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy to improve blood glucose control in patients with type 2 diabetes. It can be administered alone, and in cases where blood glucose control is inadequate, it can be used in combination with other oral hypoglycemic agents or insulin. Particularly, when there is insufficient effect from sulfonylureas or metformin monotherapy, this medication can be administered together with metformin to improve blood glucose control. This medication effectively assists patients in managing their blood glucose and supports stable blood glucose control.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses exceeding 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the required dose of this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the efficacy and duration of action of the previously administered drug. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this drug, and regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate ingestion of sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for glycemic control. There is a risk of hypoglycemia when this drug is administered with metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Individuals allergic to this medication or its components should also avoid taking it. Patients with severely impaired liver or kidney function are advised against using this medication. It is also safer for women who are pregnant or may become pregnant, as well as for nursing mothers, to avoid taking this medication. Insulin therapy is more appropriate for patients with severe infections, those before and after surgery, or those who have suffered major injuries. Patients with gastrointestinal disorders such as diarrhea or vomiting should be cautious as there is a risk of hypoglycemia. During the first week of administration, there is a higher risk of hypoglycemia, so blood glucose levels should be closely monitored. Particularly, elderly patients, those with poor nutritional status or who skip meals, and those with an unbalanced exercise and carbohydrate intake need to take extra precautions. Patients who frequently consume alcohol or have weakened liver and kidney functions may also be sensitive to hypoglycemia. If taking other medications simultaneously, blood glucose control may be compromised due to drug interactions, so it is important to consult with a physician. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and loss of consciousness; immediate action should be taken if these symptoms occur. Visual disturbances or gastrointestinal symptoms may also rarely appear, so it is important to report any unusual symptoms. Symptoms of impaired liver function or blood abnormalities may also occur, necessitating regular check-ups. If allergic reactions occur, the medication should be discontinued immediately and medical personnel informed. This medication should be taken regularly, and optimal blood glucose control can be maintained alongside dietary management and exercise. In events of hypoglycemia, foods containing sugar should be consumed immediately to manage symptoms. During pregnancy or breastfeeding, insulin therapy is recommended instead of this medication. Safety and efficacy have not been established for children under 18 years of age, hence it is not used in this population. In case of overdose, hypoglycemic symptoms may worsen, so immediate medical consultation is necessary for appropriate treatment. This medication should be kept out of the reach of children and stored in its original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, hemiparesis, sensory disturbances, dizziness, lethargy, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased hepatic enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, thus it should be stored in a tightly sealed container. Moreover, it is best to store the medication at a temperature between 1 degree and 30 degrees Celsius at room temperature. Storing it this way will help maintain the medication's effectiveness for a longer duration.
Green rectangular tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.